WO2008061966A8 - New use of flibanserin - Google Patents
New use of flibanserinInfo
- Publication number
- WO2008061966A8 WO2008061966A8 PCT/EP2007/062527 EP2007062527W WO2008061966A8 WO 2008061966 A8 WO2008061966 A8 WO 2008061966A8 EP 2007062527 W EP2007062527 W EP 2007062527W WO 2008061966 A8 WO2008061966 A8 WO 2008061966A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flibanserin
- new use
- ht2b
- medicament
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Abstract
The invention relates to the use of flibanserin for preparing a medicament for treating diseases in which the use of therapeutic effective amounts of compounds displaying affinity for the 5-HT2B-receptor display a therapeutic benefit.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06124575 | 2006-11-22 | ||
EP06124575.9 | 2006-11-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008061966A2 WO2008061966A2 (en) | 2008-05-29 |
WO2008061966A3 WO2008061966A3 (en) | 2008-07-10 |
WO2008061966A8 true WO2008061966A8 (en) | 2008-09-04 |
Family
ID=39201544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/062527 WO2008061966A2 (en) | 2006-11-22 | 2007-11-20 | New use of flibanserin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008061966A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011004284A (en) * | 2008-10-22 | 2011-06-21 | Sam Amer & Co Inc | Method for treating pulmonary arterial hypertension. |
CN103467596A (en) * | 2012-06-06 | 2013-12-25 | 北京大学 | Novel target spot for treatment of pulmonary arterial hypertension |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2450093C (en) * | 2001-08-02 | 2008-09-23 | Bidachem S.P.A. | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US20060120972A1 (en) * | 2004-11-09 | 2006-06-08 | Peter Engels | 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension |
-
2007
- 2007-11-20 WO PCT/EP2007/062527 patent/WO2008061966A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008061966A3 (en) | 2008-07-10 |
WO2008061966A2 (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1206368A1 (en) | Targeting complement factor h for treatment of diseases by the sue of cr2-fh molecules cr2-fh h | |
WO2007128802A3 (en) | Use of flibanserin for the treatment of post-menopausal sexual desire disorders | |
EP2151435A4 (en) | Pharmaceutical composition for treatment of alzheimer's disease | |
TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
IL213407A (en) | Use of combinations of therapeutic agents for the manufacture of medicaments for combination therapy | |
WO2008076847A3 (en) | Regional delivery of therapeutic agents for the treatment of vascular diseases | |
HK1163500A1 (en) | Pharmaceutical composition for the treatment of heart diseases | |
SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
IL210589A (en) | Use of a tuberculosis rv2386c protein in the manufacture of a medicament for the treatment or prevention of tuberculosis | |
WO2006108582A3 (en) | Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis | |
IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
PT2056842E (en) | Modified-galactosyl ceramide for the treatment of cancerous diseases | |
IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
PL1871399T3 (en) | Use of lecithin as a medicament for treating psoriasis | |
WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
IL192415A0 (en) | Pharmaceutical composition for the treatment of nail diseases | |
EP2306824A4 (en) | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of alzheimer's disease | |
EP2026822A4 (en) | Topical treatment for diseases of eye surface | |
PT2056804E (en) | Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases | |
EP2320939A4 (en) | Tissue kallikrein for the treatment of parkinson's disease | |
IL240394B (en) | Use of alemtuzumab for the preparation of a medicament for use as a second line therapy for the treatment of multiple sclerosis (ms) | |
WO2008031835A3 (en) | Method of treating autoimmune diseases using vegf-pathway inhibitors | |
WO2011113000A8 (en) | Novel ester containing compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07847216 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07847216 Country of ref document: EP Kind code of ref document: A2 |